Ketamine and The Hype Around It
I was surprised to learn that the antidepressant effects of ketamine were completely blocked by naltrexone, an opioid antagonist. That certainly suggests ketamine is making use of the brain’s opioid systems...
Select Page
by C. Scott McMillin | Oct 10, 2022 | Addictive Substances | 0 |
I was surprised to learn that the antidepressant effects of ketamine were completely blocked by naltrexone, an opioid antagonist. That certainly suggests ketamine is making use of the brain’s opioid systems...
by C. Scott McMillin | Aug 15, 2022 | Thinking About Addiction | 0 |
by C. Scott McMillin | May 9, 2022 | Addictive Substances | 0 |
by C. Scott McMillin | Apr 14, 2022 | Addictive Substances | 0 |
by C. Scott McMillin | Mar 31, 2022 | Treatment | 0 |
by C. Scott McMillin | Feb 7, 2022 | In the News | 0 |
by C. Scott McMillin | Dec 13, 2021 | Addictive Substances | 0 |
Originally developed to replace PCP as a fast-acting anesthetic, it quickly morphed into a party drug, then as another product sold in street drug markets.
Read Moreby C. Scott McMillin | Oct 28, 2021 | Addictive Substances | 0 |
Some genuinely bad news: a larger-than-usual share of the fakes are likely to exceed the two-milligram threshold for a potentially lethal dose of fentanyl. As many as two in five, according to DEA.
Read Moreby C. Scott McMillin | Oct 25, 2021 | In the News | 0 |
…they’ll argue that since the doctors wrote the prescriptions, there’s no way the pharmacists could be expected to refuse them.
Read Moreby C. Scott McMillin | Sep 6, 2021 | In the News | 0 |
Now this really sounds like what we heard from Purdue Pharma in the early days of the Oxycontin epidemic.
Read Moreby C. Scott McMillin | Jun 3, 2021 | Addiction Clinicians | 0 |
I’ve heard from various physicians over the years that as patient visits grow ever briefer– down to 11 minutes in some clinical settings– doctors are increasingly quick with the prescription pad.
Read Moreby C. Scott McMillin | Mar 29, 2021 | Public Policy | 0 |
It’s the opposite of transparency, and greatly limits opportunities to improve the system, so as to reduce the risk of future boondoggles.
Read Moreby C. Scott McMillin | Nov 16, 2020 | In the News | 0 |
In my experience, those folks at Corporate track everything that affects their revenue and profit margins.
Read Moreby C. Scott McMillin | Oct 19, 2020 | In the News | 0 |
(fines) are unlikely to be paid in the near term as the criminal fine and civil penalty are expected to be considered alongside other claims in Purdue’s bankruptcy proceedings and the company lacks necessary funds to fully repay all creditors…
Read Moreby C. Scott McMillin | Oct 15, 2020 | Addictive Substances, Public Policy | 0 |
For a long time, many medical professionals were resistant to the idea that benzos could be hazardous unless the patient took too many at once, or mixed them with alcohol.
Read Moreby C. Scott McMillin | Sep 7, 2020 | In the News | 0 |
It’s clear Purdue execs knew far more about the dangers of Oxycontin than they were willing to acknowledge. They may simply have lied about it…
Read Moreby C. Scott McMillin | Aug 3, 2020 | In the News | 0 |
The juxtaposition of the two accounts – raw devastation to a family on one hand, and on the other, superrich individuals with high-paid legal talent celebrating after pulling a fast one on the “system” – paints things in a harsher light.
Read Moreby C. Scott McMillin | Mar 5, 2020 | Bookshelf | 0 |
In fact, in many instances, the trauma that occurs after they’re addicted is more damaging than what happened before.
Read More